Literature DB >> 31812070

Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level.

Wei Wang1, Shiqi Ren1, Ziheng Wang1, Chenlin Zhang2, Jianfei Huang3.   

Abstract

BACKGROUND: Lung adenocarcinoma (LUAD) is a crucial pathological type of lung cancer. Immune-infiltration of the tumor microenvironment positively associated with overall survival in LUAD. TTC21A is a gene has not reported in cancer, and the mechanism behind it is still unclear. Our study assesses TTC21A role in LUAD, via TCGA data.
METHODS: GEPIA was utilized to analyze the expression of TTC21A in LUAD. We evaluated the influence of TTC21A on survival of LUAD patients by survival module. Then, data sets of LUAD were downloaded from TCGA. The correlations between clinical information and TTC21A expression were analyzed using logistic regression. Clinicopathologic characteristics associated with overall survival in TCGA patients using Cox regression. In addition, we explored the correlation between TTC21A and cancer immune infiltrates using CIBERSORT and "Correlation" module of GEPIA.
RESULTS: The univariate analysis using logistic regression, wherein TTC21A expression served as a categorical dependent variable (with a median expression value of 2.5), indicated that increased TTC21A expression is significantly correlated with pathological stage, tumor status and lymph nodes. Moreover, multivariate analysis revealed that the up-regulated TTC21A expression, negative results of pathological stage and distant metastasis are independent prognostic factors for good prognosis. Specifically, a positive correlation between increased TTC21A expression and immune infiltrating level of B cells, Neutrophils, Mast cells and T cells was established using CIBERSORT analysis. Furthermore, we confirmed it in "correlation" module of GEPIA.
CONCLUSION: Together with all these findings, increased TTC21A expression correlates with favorable prognosis and increased proportion of immune cells, such as B cells, Neutrophils, Mast cells and T cells in LUAD. These conclusions indicate that TTC21A could serve as a potential biomarker to assess prognosis and immune infiltration level in LUAD.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biomarker; Immune infiltration; Lung adenocarcinoma; Lymphocyte; Prognosis; TTC21A

Year:  2019        PMID: 31812070     DOI: 10.1016/j.intimp.2019.106077

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  14 in total

1.  miR-873 and miR-105-2 May Affect the Tumour Microenvironment and are Potential Biomarkers for Lung Adenocarcinoma.

Authors:  Hao Zhang; Yan Liu; Zhihong Xu; Quan Chen
Journal:  Int J Gen Med       Date:  2022-03-29

2.  Prognostic value of Holliday junction-recognizing protein and its correlation with immune infiltrates in lung adenocarcinoma.

Authors:  Long Chen; Chong Zeng; Limei Yan; Wanyu Liao; Chen Zhen; Jie Yao
Journal:  Oncol Lett       Date:  2022-05-27       Impact factor: 3.111

3.  Thm2 interacts with paralog, Thm1, and sensitizes to Hedgehog signaling in postnatal skeletogenesis.

Authors:  Bailey A Allard; Wei Wang; Tana S Pottorf; Hammad Mumtaz; Brittany M Jack; Henry H Wang; Luciane M Silva; Damon T Jacobs; Jinxi Wang; Erin E Bumann; Pamela V Tran
Journal:  Cell Mol Life Sci       Date:  2021-03-08       Impact factor: 9.207

4.  Establishment of Immune-related Gene Pair Signature to Predict Lung Adenocarcinoma Prognosis.

Authors:  Xueping Jiang; Yanping Gao; Nannan Zhang; Cheng Yuan; Yuan Luo; Wenjie Sun; Jianguo Zhang; Jiangbo Ren; Yan Gong; Conghua Xie
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

5.  The construction and analysis of ceRNA network and patterns of immune infiltration in lung adenocarcinoma.

Authors:  Jinglong Li; Wenyao Liu; Xiaocheng Dong; Yunfeng Dai; Shaosen Chen; Enliang Zhao; Yunlong Liu; Hongguang Bao
Journal:  BMC Cancer       Date:  2021-11-16       Impact factor: 4.430

6.  Overexpression of PTPRN Promotes Metastasis of Lung Adenocarcinoma and Suppresses NK Cell Cytotoxicity.

Authors:  Xinyue Song; Xue Jiao; Han Yan; Lifeng Yu; Longyang Jiang; Ming Zhang; Lianze Chen; Mingyi Ju; Lin Wang; Qian Wei; Lin Zhao; Minjie Wei
Journal:  Front Cell Dev Biol       Date:  2021-06-02

7.  The effect of CCL5 on the immune cells infiltration and the prognosis of patients with kidney renal clear cell carcinoma.

Authors:  Shuheng Bai; YinYing Wu; Yanli Yan; Haojing Kang; Jiangzhou Zhang; Wen Ma; Ying Gao; Beina Hui; Rong Li; Xiaozhi Zhang; Juan Ren
Journal:  Int J Med Sci       Date:  2020-10-18       Impact factor: 3.738

8.  Exome-Sequence Analyses of Four Multi-Incident Multiple Sclerosis Families.

Authors:  Tobias Zrzavy; Fritz Leutmezer; Wolfgang Kristoferitsch; Barbara Kornek; Christine Schneider; Paulus Rommer; Thomas Berger; Alexander Zimprich
Journal:  Genes (Basel)       Date:  2020-08-25       Impact factor: 4.096

9.  Complement C1q (C1qA, C1qB, and C1qC) May Be a Potential Prognostic Factor and an Index of Tumor Microenvironment Remodeling in Osteosarcoma.

Authors:  Long-Hao Chen; Jin-Fu Liu; Yan- Lu; Xin-Yu He; Chi- Zhang; Hong-Hai Zhou
Journal:  Front Oncol       Date:  2021-05-17       Impact factor: 6.244

10.  High expression of PIMREG predicts poor survival outcomes and is correlated with immune infiltrates in lung adenocarcinoma.

Authors:  Feng Jiang; Min Liang; Xiaolu Huang; Wenjing Shi; Yumin Wang
Journal:  PeerJ       Date:  2021-07-06       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.